Curcumin has anticonvulsant activity on increasing current electroshock seizures in mice

Phytotherapy Research

Volumn 22, Issue 12, 2008, Pages 1660-1664

  Bharal, Nidhi ^a   Sahaya, Kinshuk ^a   Jain, Seema ^a   Mediratta, Pramod K ^a   Sharma, Krishna K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Anticonvulsant; Anxiety; Curcumin; Electroshock; Turmeric

Indexed keywords

CURCUMAXA; CURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC SHOCK; FEMALE; MALE; MAZE TEST; MOUSE; NONHUMAN; SEIZURE; SEIZURE THRESHOLD;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; CURCUMA; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; FEMALE; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; SEIZURES;

CURCUMA LONGA; MUS;

EID: 57549084096     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2551     Document Type: Article

References (40)

1. Ammon HPT, Wahl MA. 1991. Pharmacology of Curcuma longa. Planta Med 57: 1-7.
2. Bharal N, Pillai KK, Vohora D. 2006. Effects of sparfloxacin on CNS functions and urinary hydroxyproline in mice. Pharmacol Res 54: 111-117.
3. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN. 1969. Screening of Indian plants for biological activity. Part II. Indian J Exp Biol 7: 250-262.
4. Curcumaxa, Curcumin, Curcuma longa, 85-98% curcuminoids http://www.kancor.in/php/homeSearchFrm.php
5. Dhar ML, Dhar MM, Dhawan BN, Ray C. 1968. Screening of Indian plants for biological activity. Part I. Indian J Exp Biol 6: 232-247.
6. Dikshit M, Rastogi L, Shukla R, Srimal RC. 1995. Prevention of ischemia-induced biochemical changes by curcumin and quinidine in the cat heart. Indian J Med Res 101: 31-35.
7. Frautschy SA, Hu W, Kim P, Miller SA, Chu T Harris-White ME, Cole GM. 2001. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22: 993-1005.
8. Ghoneim AI, Abdel-Naim AB, Khalifa A, El-Denshary ES. 2002. Protective effects of curcumin against ischemia/reperfusion insult in rat forebrain. Pharmacol Res 46: 273-279.
9. Gupta YK, Malhotra J. 2000. Antiepileptic drug therapy in the twenty first century. Indian J Physiol Pharmacol 4: 8-23.
10. Hardman JG, Limbird LE, Gilman AG. 2001. The Pharmacological Basis of Therapeutics. McGraw Hill: New York, USA.
11. Hintze J. 2001. NCSS and PASS. Number cruncher statistical systems. Ness Technologies: Kaysville, Utah. www.ncss.com
12. Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, Kim TS. 1999. Curcumin inhibits Th1 cytokine profile in CD 4+ T cells by suppressing Interleukin 12 production in macrophages. Br J Pharmacol 128: 380-384.
13. Kitano Y, Chiharu U, Takasuna K, Hirohashi M. 1996. ICES test, A new method for assessment of anti- and proconvulsive activities of drugs in mice. J Pharmacol Toxicol Meth 35: 25-29.
14. Kulkarni SK, Dandiya PC. 1975. Influence of intraventricular administration of norepinephrine, dopamine and 5-hydroxytryptamine on motor activity of rats. Indian J Med Res 63: 462-468.
15. Kulkarni SK. 2002. Handbook of experimental pharmacology (3rd edition). Vallabh Prakashan: Delhi.
16. Larmet Y, Reibel S, Carnahan J, Nawa H, Marescaux C, Depaulis A. 1995. Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 6: 1937-1941.
17. Linn GP, Chu T, Yang FS, Beech W, Frautschy S. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377.
18. Maertns P, Dyken P, Graf W, Pippenger C, Chronister R, Shah A. 1995. Free radicals, anticonvulsants and the neuronal ceroid-lipofuscinoses. Am J Med Genet 57: 225-228.
19. Marwah R, Pillai KK, Pal SN. 1998. Effect of fluoxetine alone and in combination with anticonvulsants on the increasing current electroshock test. M.Pharm. Thesis, Jamia Hamdard, New Delhi; 32-39.
20. Medirata PK, Sharma KK, Rana J. 2001. Development of differential tolerance to the sedative and anti-stress effects of benzodiazepines. Indian J Physiol Pharmacol 45: 111-115.
21. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. 2006. Curry consumption and cognitive function in the elderly. Am J Epidemiol 164: 898-906.
22. Ono K, Hasegawa K, Naiki H, Yamada M. 2004. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75: 742-750.
23. Osehobo P, Adams B, Sazgar M, Xu Y, Racine RJ, Fahnestock M. 1999. Brain-derived neuotrophic factor infusion delays and perforant path kindling without affecting paired-pulse measures of neuronal inhibition in adult rats. Neuroscience 92: 1367-1375.
24. Pellow S, Phillipe C, File S, Briley M. 1985. Validation of open close arm entries in an elevated plus maze as a measure of anxiety in rat. J Neurosci Meth 14: 149-167.
25. Rajkumar DV, Rao MN. 1994. Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol Cell Biochem 140: 73-79.
26. Rao CV, Rivenson A, Simi B, Reddy BS. 1995. Chemoprevention of colon carcinogenesis by dietary curcumin. A naturally occurring plant phenolic compound. Cancer Res 55: 259-266.
27. Reibel S, Larmet Y, Le Bt, Carnahan J, Marescaux C, Depaulis A. 2000. Brain-derived neurotrophic factor delays hippocampal kindling in the rat. Neuroscience 100: 777-788.
28. Roberto M, Roberta F, Rekha B, Colin JG. 2000. Curcumin, an antioxidant and anti-inflammatory agent induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28: 1303-1312.
29. Rosenberg HC, Chui TH. 1981. Tolerance during chronic benzodiazepine treatment associated with decrease receptor binding. Eur J Pharmacol 70: 453-460.
30. Sarup PNV. 1977. Handbook of Medicinal plants. Central council of Research in Indian Medicine and Homoeopathy (CCRIMH): New Delhi.
31. Schmitz B. 2006. Effects of antiepileptic drugs on mood and behavior Epilepsia 47: 28-33s.
32. Shin HJ, Lee JY, Son E, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS. 2007. Curcumin attenuate the kainic acid-induced hippocampal cell death in mice. Neurosci Lett 416: 49-54.
33. Shoskes DA. 1998. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agernt. Transplantation 66: 147-152.
34. Shukla PK, Khanna VK, Khan MY, Srimal RC. 2003. Protective effect of curcumin against lead neurotoxicity in rat. Human Exp Toxicol 22: 653-658.
35. Teitz EL, Rosenberg MC, Chui TH. 1986. Autoradiographic localization of benzodiazepine receptor down regulation. J Pharmacol Exp Ther 236: 284-292.
36. Thiyagarjan S, Sharma SS. 2004. Neuroprotective effect of curcumin in middle artery occlusion induced focal cerebral ischemia in rats. Life Sci 74: 969-985.
37. Torbati D, Church DF, Keller JM, Pryor WA. 1992. Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. Free Radic Biol Med 13: 101-106.
38. Wu A, Ying Z, Pinilla FG. 2006. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol 197: 309-317.
39. Xu Y, Ku BA, Yao HY, Lin YH, Ma, Zhang YH, Li XJ. 2005. The effects of curcumin on depressive-like behaviour in mice. Eur J Pharmacol 518: 40-46.
40. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaonkar SS, Chen PP, Kayed R, Glabe CG, Fraetschy SA, Cole GM. 2005. Curcumin inhibits formation of amyloid beta oligomers and fibrils, bind plaques and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.